News
2d
MedPage Today on MSNGLP-1 Med Users See Drop in Recurrent Afib EventsAnother benefit of GLP-1 receptor agonist (RA) use may be protection from persistent atrial fibrillation (Afib or AF) after ...
The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.
A woman who privately purchased an injectable GLP-1 weight-loss medication is claiming it made her hair fall out and gave her ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.
Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. | Eli Lilly has met its goal of ...
Years ago, Robyn Munsch would wander hungrily around the grocery store and leave with calorie-dense foods like a frozen pizza, cookies and frosting. That was before she started taking Wegovy and lost ...
Recent consumer research by product development group AMC Global and OpinionRoute, LLC reveals the evolving preferences of ...
Jamie Mafdali of South Florida was hit with a cancer double-whammy three years ago. Shortly after her mother began treatment ...
U.S.-listed shares of Novo Nordisk plunged 7% in intraday trading Thursday after rival Eli Lilly reported positive oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results